Aardvark Therapeutics, Inc. Common Stock (AARD)
NASDAQ·Healthcare·Biotechnology
$3.88
+4.31%
Mkt Cap $120.42M
Analyst Ratings
Buy
5
Hold
3
Sell
0
Price Target (7 analysts)
$22.75
Range $3.00 – $47.00
Implied Upside
+486.3%
Consensus $22.75 vs current $3.88